Joseph Giangola from Hackensack University Medical Center: Making Strides In Treating Type 1 Diabetes

%jwplayer%

While the number of treatments for type 1 diabetes lags behind those for type 2 there is still a lot of work being done to help these patients thanks in large part to technological advances.

Joseph Giangola, MD, from Hackensack University Medical Center, now known as HackensackUMC, discussed both current and future treatments during an interview with MD Magazine. One of the most promising developments in the pipeline, according to Giangola, is the artificial pancreas which could prove to be an invaluable tool for these patients much like the insulin pump has become for patients with type 2 diabetes.